Rydapt
midostaurin
Leukemia, Myeloid, Acute
Mastocytosis
Date of authorisation:
Revision: 11
Last updated:
MedicineHumanAuthorised
Valdoxan
Agomelatine
Depressive Disorder, Major
Date of authorisation:
Revision: 24
Last updated:
MedicineHumanAuthorised
EMEA-000780-PIP01-09-M06 - paediatric investigation plan
Decision type: PM: decision on the application for modification of an agreed PIP
Therapeutic area: Oncology
PIP number: P/0086/2021
Route(s) of administration: Oral use
Pharmaceutical form(s):
Oral solution
Capsule (soft)
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
Valdoxan
Agomelatine
Depressive Disorder, Major
Date of refusal:
Last updated:
MedicineHumanRefused